Skip to main content
SecondaryClaims
Back to Condition Library

Kidney Cancer PACT Act Presumptive

How veterans claim kidney cancer (renal cell carcinoma) as a PACT Act presumptive condition from toxic exposure. Covers eligibility, 100% cancer rating, evidence, and filing guidance.

Last updated: 2026-04-18

What Is Kidney Cancer as a PACT Act Presumptive?

Renal cell carcinoma (RCC) is the most common type of kidney cancer, accounting for approximately 90% of kidney malignancies. For veterans with qualifying toxic exposure histories under the PACT Act, kidney cancer is a presumptive service-connected condition — allowing veterans with kidney cancer diagnoses and qualifying service to establish service connection without needing to prove a direct causal link.

Veterans diagnosed with kidney cancer after service in Southwest Asia, Afghanistan, and other covered locations should file immediately. Active cancer receives an automatic 100% VA rating during treatment, and post-treatment ratings are based on kidney function residuals and the extent of surgical treatment required.

The chemical exposures common in military service — particularly trichloroethylene (a solvent used extensively in aircraft and electronics maintenance), perchloroethylene, and other halogenated organic solvents — have established carcinogenic links to renal cell carcinoma in occupational medicine literature. The PACT Act's inclusion of kidney cancer reflects these documented exposure-cancer relationships.

Why the VA Recognizes This Connection

Trichloroethylene (TCE) and renal carcinogenesis. TCE is a known Group 1 human carcinogen for kidney cancer (IARC classification). Military aircraft maintenance, electronics cleaning, and industrial degreasing operations involved extensive TCE use for decades. Veterans with occupational exposure to TCE have documented elevated kidney cancer risks.

Perchloroethylene (PERC) and kidney cancer. PERC, used extensively in military dry cleaning operations, is classified as a probable human carcinogen with established kidney cancer associations.

Burn pit polycyclic aromatic hydrocarbons. PAHs from combustion are nephrotoxic and potentially carcinogenic through metabolic activation to reactive epoxides that form DNA adducts in kidney tubular cells.

Cadmium and heavy metal exposure. Military operations involving batteries, electronic equipment, and certain munitions expose veterans to cadmium — a known kidney carcinogen and nephrotoxin — at levels that may exceed occupational safety thresholds.

Arsenic exposure. Certain military environments — including contaminated water sources in deployed locations — involve arsenic exposures linked to kidney cancer development.

The VA's toxic exposure and cancer presumptives page provides the regulatory basis.

Evidence That Wins This Claim

For the presumptive pathway:

  • Proof of qualifying service: DD-214 documenting service in covered locations.
  • Kidney cancer diagnosis: Pathology report from biopsy or nephrectomy confirming malignant renal neoplasm.
  • Oncology and urology records: Treatment records documenting diagnosis, staging, and treatment plan.
  • Imaging records: CT scan or MRI confirming renal mass and staging.

Supporting documentation:

  • Surgical records: Nephrectomy records documenting extent of surgery and pathological staging.
  • Post-treatment oncology follow-up: Records documenting surveillance imaging and cancer status post-treatment.

How the VA Rates Kidney Cancer

Active kidney cancer is rated under DC 7528 (Malignant neoplasms of the genitourinary system):

StatusRating
During active treatment100% automatic
Remission (6-month post-treatment evaluation)Rated under kidney function residuals
Nephrectomy residualsDC 7504: 30% for nephrectomy

Post-treatment kidney function impairment (from partial or total nephrectomy, radiation damage, or chemotherapy nephrotoxicity) is separately rated under the kidney disease schedule based on BUN, creatinine, and eGFR values.

Why These Claims Get Denied — And How to Prevent It

Filing delayed after diagnosis. File immediately after diagnosis. Delay results in delayed 100% rating and back-pay that could support the veteran and family during treatment.

Qualifying service not documented. Ensure service records reflect deployment to covered locations.

Post-treatment re-evaluation not filed. After the initial 100% rating at 6-month follow-up, if residuals remain, an updated rating claim should be filed based on kidney function and surgical residuals.

Survivors unaware of DIC. If a veteran dies of service-connected kidney cancer, surviving family may be entitled to DIC and other survivor benefits.

Cancer attributed to tobacco or other factors. The PACT Act presumptive pathway does not require ruling out other risk factors — it presumes service connection based on qualifying service and diagnosis.

Related Conditions

Next Steps

File immediately after diagnosis. For urgent cancer claims, contact a VA-accredited VSO for same-day filing assistance. See the PACT Act Claims Playbook for step-by-step guidance.


This is educational content, not legal advice. SecondaryClaims.com is not accredited by the VA under 38 CFR § 14.629. For accredited representation, consult a VA-accredited VSO, claims agent, or attorney at https://www.va.gov/ogc/apps/accreditation/.